Articles on this page are updated by ProfileData Research on an hourly basis. To see the summary of the SENS notice, please click on the headline. To read the original SENS message, please click on the link in the summary.



Date Headline/Title
31 December 2013Acquisition of a portfolio of products from MSD-All conditions precedent met
31 December 2013Further Announcement Relating To The Acquisition By Aspen Of The Glaxosmithkline Groups (Gsk) Arixtra And Fraxipa
31 December 2013Acquisition of a portfolio of products from MSD-All conditions precedent met
31 December 2013Further Announcement Relating To The Acquisition By Aspen Of The Glaxosmithkline Groups (Gsk) Arixtra And Fraxipa
20 December 2013Competition Tribunal approval
04 December 2013Directors Dealings
04 December 2013Results of AGM
20 November 2013Notification in terms of S122(3) of the Companies Act and S3.83(b) of the JSE Listings Requirements
19 November 2013Dealing in securities by Directors and by Directors of major subsidiaries
11 November 2013Results of Extraordinary General Meeting of Shareholders to approve proposed GSK Transaction
04 November 2013No change statement and AGM
31 October 2013Dealing in Aspen Securities by Directors of a major subsidiary
31 October 2013Acquisition from MSD
28 October 2013Completion of acquisition of Infant Nutritional businesses in Latin America from Nestle
24 October 2013Conclusion of arrangements in respect of acquisition finance facilities
18 October 2013Dealing in Aspen Securities by a Director of a major subsidiary
14 October 2013Dealing in Securities by Directors Company Secretary and Directors of a major subsidiary
14 October 2013Dealing in Securities by a Director and Directors of a major subsidiary
11 October 2013Directors Dealings
10 October 2013Posting of circular and notice of general meeting
01 October 2013Acquisition fr
01 October 2013Acquisition from MSD of an API manufacturing business and portfolio of products by Aspen: Conditions precedent met
30 September 2013Aspen -Acquisition by Aspen of GlaxoSmithKline plc
30 September 2013Acquisition by Aspen of GlaxoSmithKline plcs Arixtra and Fraxiparine/Fraxodi brands
13 September 2013US$2 035 000 000 and ZAR 7 330 000 000Acquisition Finance Facilities
13 September 2013Record Date
11 September 2013Aspen final results June 2013
05 September 2013Renewal of Cautionary
30 August 2013Trading Statement
07 August 2013Acquisition of Infant Nutritional businesses from Nestle - Voluntary Announcement
24 July 2013Renewal of Cautionary Announcement- Discussions with GSK
27 June 2013Signed agreeme
27 June 2013Signed agreements for acquisition and Renewal of Cautionary
18 June 2013Cautionary Announcement
03 June 2013Renewal of Cautionary Announcement - Discussions with MSD
23 April 2013Renewal of Cautionary Announcement
18 April 2013Acquisition of Infant Nutritional Businesses from Nestle
07 March 2013Aspen interim results 31 December 2012
21 February 2013Trading Statement
04 February 2013Cautionary announcement - discussions with MSD
04 February 2013Cautionary announcement - discussions with MSD
Powered by ProfileData